PCOS and menopause are rarely discussed, yet it could affect 1 in 10 women in the UK. Here, Health Writer Sarah Finley ...
Astellas Pharma today announced that the US Food and Drug Administration (FDA) has approved VYLOY (zolbetuximab-clzb) in ...
Meanwhile, some people might notice they can no longer tolerate the cold—which is one sign of hypothyroidism, or an ...
Tom Kurtz has worked for years to help spread awareness of breast cancer detection and treatment. After a personal health ...
The company provides generic pharmaceuticals for the treatment of pancreatic ... intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, ...
You're supposed to shed a few hair strands a day, but how much hair loss is normal? Experts weigh in on the hair life cycle ...
Medically reviewed by Kashif J. Piracha, MD Medically reviewed by Kashif J. Piracha, MD Chronic kidney failure, or end-stage ...
VYLOY is the first and only CLDN18.2-targeted treatment approved in the U.S. for adults with advanced gastric and gastroesophageal junction cancer whose tumors are CLDN18.2 positive TOKYO, Oct. 18 ...
It is a severe, whole-body reaction that requires immediate medical attention. Anaphylaxis can occur when a person’s immune ...